Congo Begins Ebola Vaccinations as Bundibugyo Protection Remains Uncertain
Congo has begun vaccinating Ebola responders with Ervebo, while a 20,000-dose trial will test whether it protects against Bundibugyo virus.
Congo has begun vaccinating Ebola responders with Ervebo, while a 20,000-dose trial will test whether it protects against Bundibugyo virus.
The Bundibugyo-virus outbreak in eastern Congo began in February but was not declared until mid-May, WHO says, as transmission outpaces contact tracing and health services.